NeuroRx Awarded FDA Fast Track Designation for First Drug Regimen Targeting Suicide in Bipolar Depression

Company to present at Rodman and Renshaw Global Investment Conference in New York City on Sept 12, 2017 WILMINGTON, Del., Sept. 6, 2017 -- (Healthcare Sales & Marketing Network) -- NeuroRx, a clinical stage biopharma company developing the first oral t... Biopharmaceuticals, FDA NeuroRx, D-cycloserine, lurasidone, Bipolar Depression
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news